{"transactions":[{"id":1791716,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":110067,"kind":"person","name":"Lopatin Uri A","position":1,"cik":"0001613259","reported_name":"Lopatin Uri A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-31T14:47:14.000Z","date":"2023-08-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":421000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":11.32,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":421000},"source":{"system":"sec-edgar","filing":"0001209191-23-047827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1613259/000120919123047827/doc4.xml","form_type":"4"}},{"id":1791715,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":110067,"kind":"person","name":"Lopatin Uri A","position":1,"cik":"0001613259","reported_name":"Lopatin Uri A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-31T14:47:14.000Z","date":"2023-08-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":37500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each option to purchase shares granted under an Issuer equity plan (each, a Company Stock Option) that was outstanding and unvested as of that date. As of the Effective Time, each in-the-money Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled in-the-money Company Stock Option was entitled to receive, in consideration of the cancellation of such Company Stock Option, (i) an amount in cash (less applicable tax withholdings and without interest) equal to the product of (x) the total number of shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess of $2.13 over the applicable exercise price per share under such Company Stock Option and (ii) one contingent value right for each share subject thereto."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each option to purchase shares granted under an Issuer equity plan (each, a Company Stock Option) that was outstanding and unvested as of that date. As of the Effective Time, each in-the-money Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled in-the-money Company Stock Option was entitled to receive, in consideration of the cancellation of such Company Stock Option, (i) an amount in cash (less applicable tax withholdings and without interest) equal to the product of (x) the total number of shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess of $2.13 over the applicable exercise price per share under such Company Stock Option and (ii) one contingent value right for each share subject thereto."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each option to purchase shares granted under an Issuer equity plan (each, a Company Stock Option) that was outstanding and unvested as of that date. As of the Effective Time, each in-the-money Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled in-the-money Company Stock Option was entitled to receive, in consideration of the cancellation of such Company Stock Option, (i) an amount in cash (less applicable tax withholdings and without interest) equal to the product of (x) the total number of shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess of $2.13 over the applicable exercise price per share under such Company Stock Option and (ii) one contingent value right for each share subject thereto."}],"balance_after":0,"derivative":{"exercise_price":1.87,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-23-047827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1613259/000120919123047827/doc4.xml","form_type":"4"}},{"id":1791714,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":110067,"kind":"person","name":"Lopatin Uri A","position":1,"cik":"0001613259","reported_name":"Lopatin Uri A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-31T14:47:14.000Z","date":"2023-08-31","kind":"other","planned":false,"acquired":false,"shares":351948,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger entered into by and among the Issuer, MediPacific, Inc. (Parent) and MediPacific Sub, Inc., a wholly-owned subsidiary of Parent (Purchaser), dated as of July 16, 2023 (Merger Agreement), pursuant to which the Purchaser completed a tender offer for the shares of common stock of the Issuer and thereafter merged with and into the Issuer effective as of August 31, 2023 (Effective Time)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement and Purchaser's offer to purchase, the shares of common stock were tendered to Purchaser in consideration for a per share price of (i) $2.13 in cash, net of applicable taxes and without interest, and (ii) one non-transferable contractual contingent value right."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person and his spouse are co-trustees of the Lopatin Descendants' Trust (Trust). The Reporting Person disclaims Section 16 beneficial ownership of the securities held by the Trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-047827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1613259/000120919123047827/doc4.xml","form_type":"4"}},{"id":1791713,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":110067,"kind":"person","name":"Lopatin Uri A","position":1,"cik":"0001613259","reported_name":"Lopatin Uri A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-31T14:47:14.000Z","date":"2023-08-31","kind":"other","planned":false,"acquired":false,"shares":5327798,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger entered into by and among the Issuer, MediPacific, Inc. (Parent) and MediPacific Sub, Inc., a wholly-owned subsidiary of Parent (Purchaser), dated as of July 16, 2023 (Merger Agreement), pursuant to which the Purchaser completed a tender offer for the shares of common stock of the Issuer and thereafter merged with and into the Issuer effective as of August 31, 2023 (Effective Time)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement and Purchaser's offer to purchase, the shares of common stock were tendered to Purchaser in consideration for a per share price of (i) $2.13 in cash, net of applicable taxes and without interest, and (ii) one non-transferable contractual contingent value right."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-047827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1613259/000120919123047827/doc4.xml","form_type":"4"}},{"id":1869063,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":110067,"kind":"person","name":"Lopatin Uri A","position":1,"cik":"0001613259","reported_name":"Lopatin Uri A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T16:09:11.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continued service to the Issuer on each applicable vesting date, the option vests as to 1/12 of the total award on each monthly anniversary of the Grant Date; provided, however, that notwithstanding the monthly vesting schedule, the options shall vest in full upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the next annual meeting of the stockholders."}],"balance_after":37500,"derivative":{"exercise_price":1.87,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-23-033673","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1613259/000120919123033673/doc4.xml","form_type":"4"}},{"id":2415805,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":110067,"kind":"person","name":"Lopatin Uri A","position":1,"cik":"0001613259","reported_name":"Lopatin Uri A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-02T19:03:46.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":421000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in substantially equal monthly installments over four years from February 1, 2022, subject to a continued service relationship. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2021 Stock Option and Incentive Plan with the U.S. Securities and Exchange Commission."}],"balance_after":421000,"derivative":{"exercise_price":11.32,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":421000},"source":{"system":"sec-edgar","filing":"0000899243-22-004212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1613259/000089924322004212/doc4.xml","form_type":"4"}},{"id":3568471,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":110067,"kind":"person","name":"Lopatin Uri A","position":1,"cik":"0001613259","reported_name":"Lopatin Uri A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-02T20:36:13.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% shall vest on the first anniversary of the date of grant, March 29, 2020; and the remaining 75% shall vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2023."}],"balance_after":27500,"derivative":{"exercise_price":19.69,"expiration_date":"2029-03-29","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001144204-19-017748","document":"tv517877_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420419017748/tv517877_4.xml","form_type":"4"}},{"id":3568470,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":110067,"kind":"person","name":"Lopatin Uri A","position":1,"cik":"0001613259","reported_name":"Lopatin Uri A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-02T20:36:13.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2020; March 29, 2021; March 29, 2022; and March 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total includes 606,111 shares that are held by the Uri Lopatin Revocable Trust for which the reporting person is the trustee and sole beneficiary. Accordingly, these shares are reported as being held directly by the reporting person."}],"balance_after":627361,"source":{"system":"sec-edgar","filing":"0001144204-19-017748","document":"tv517877_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420419017748/tv517877_4.xml","form_type":"4"}},{"id":3821936,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":110067,"kind":"person","name":"Lopatin Uri A","position":1,"cik":"0001613259","reported_name":"Lopatin Uri A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Med. Off., VP Res. Dev."}}],"security":"Common Stock","published_at":"2018-09-07T20:44:56.000Z","date":"2018-09-06","kind":"sale","acquired":false,"shares":336,"price":40.006,"value":13442.016,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.02, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the price range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Total includes 606,111 shares that are held by the Uri Lopatin Revocable Trust for which the reporting person is the trustee and sole beneficiary. Accordingly, these shares are reported as being held directly by the reporting person."}],"balance_after":613611,"source":{"system":"sec-edgar","filing":"0001144204-18-048565","document":"tv502511_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420418048565/tv502511_4.xml","form_type":"4"}},{"id":3821935,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":110067,"kind":"person","name":"Lopatin Uri A","position":1,"cik":"0001613259","reported_name":"Lopatin Uri A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Med. Off., VP Res. Dev."}}],"security":"Common Stock","published_at":"2018-09-07T20:44:56.000Z","date":"2018-09-05","kind":"sale","acquired":false,"shares":15204,"price":40.0912,"value":609546.6048,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.41, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the price range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Total includes 606,447 shares that are held by the Uri Lopatin Revocable Trust for which the reporting person is the trustee and sole beneficiary. Accordingly, these shares are reported as being held directly by the reporting person."}],"balance_after":613947,"source":{"system":"sec-edgar","filing":"0001144204-18-048565","document":"tv502511_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420418048565/tv502511_4.xml","form_type":"4"}},{"id":3978728,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":110067,"kind":"person","name":"Lopatin Uri A","position":1,"cik":"0001613259","reported_name":"Lopatin Uri A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Med. Off., VP Res. Dev."}}],"security":"Stock Option (right to buy)","published_at":"2018-03-30T22:29:02.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% shall vest on the first anniversary of the date of grant, March 29, 2019; and the remaining 75% shall vest in 36 equal monthly installments, with the options becoming fully vested on March 29, 2022."}],"balance_after":15000,"derivative":{"exercise_price":49.14,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001144204-18-018347","document":"tv490034_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420418018347/tv490034_4.xml","form_type":"4"}},{"id":3978727,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":110067,"kind":"person","name":"Lopatin Uri A","position":1,"cik":"0001613259","reported_name":"Lopatin Uri A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Med. Off., VP Res. Dev."}}],"security":"Common Stock","published_at":"2018-03-30T22:29:02.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2019; March 29, 2020; March 29, 2021; and March 29, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total includes 621,651 shares that are held by the Uri Lopatin Revocable Trust for which the reporting person is the trustee and sole beneficiary. Accordingly, these shares are reported as being held directly by the reporting person."}],"balance_after":629151,"source":{"system":"sec-edgar","filing":"0001144204-18-018347","document":"tv490034_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420418018347/tv490034_4.xml","form_type":"4"}},{"id":4366756,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":110067,"kind":"person","name":"Lopatin Uri A","position":1,"cik":"0001613259","reported_name":"Lopatin Uri A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Med. Off., VP Res. Dev."}}],"security":"Stock Option (right to buy)","published_at":"2017-03-31T20:11:28.000Z","date":"2017-03-29","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over two years as follows: 50% shall vest on the first anniversary of the date of grant, March 29, 2018; and the remaining 50% shall vest in 12 equal monthly installments, with the options becoming fully vested on March 29, 2019."}],"balance_after":12500,"derivative":{"exercise_price":25.34,"expiration_date":"2027-03-29","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001144204-17-018188","document":"v463063_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420417018188/v463063_4.xml","form_type":"4"}}]}